• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Issues in formulary management: therapeutic interchange. The value, cost, and quality of therapeutic interchange.

作者信息

Mahoney C D

机构信息

Rhode Island Hospital, Providence 02903.

出版信息

Hosp Formul. 1992 Oct;27 Suppl 2:2-3.

PMID:10122035
Abstract

Therapeutic interchange is a process of substituting a prescribed medication with one that offers therapeutic and cost benefits. The practice not only provides short-term savings but also is associated with decreases in lengths of stay in hospitals and total hospital drug expenses. There may be medicolegal implications when FDA-approved indications differ for interchanged drugs. The potential for liability is decreased when a standard of care is met, but since standards can change, guidelines should be reviewed regularly. High-tech, high-cost drugs are sometimes appropriate for therapeutic interchange. Pharmacy and therapeutics committees should assure best value by considering indirect expenses, quality, and therapeutic outcome, as well as product cost. Therapeutic interchange programs enable pharmacy managers to neutralize or at least slow the rate of drug cost increases, ensuring appropriate utilization of resources and more favorable patient outcomes.

摘要

相似文献

1
Issues in formulary management: therapeutic interchange. The value, cost, and quality of therapeutic interchange.
Hosp Formul. 1992 Oct;27 Suppl 2:2-3.
2
Formulary management: antibiotics and therapeutic interchange.
Pharm Pract Manag Q. 1996 Oct;16(3):11-8.
3
Legal and medical issues in therapeutic interchange: implications for pharmacists, physicians, and P & T committees.
Hosp Formul. 1992 Oct;27(10):1040-2, 1047-8.
4
Issues in formulary management: therapeutic interchange. Establishing guidelines: roundtable discussion, Part 1.
Hosp Formul. 1992 Oct;27 Suppl 2:4-8.
5
Experience with a two-tiered therapeutic interchange policy.两层治疗性换药政策的经验
Am J Hosp Pharm. 1989 Sep;46(9):1792-8.
6
Issues in formulary management: therapeutic interchange. Communicating a policy: roundtable discussion, Part 2.
Hosp Formul. 1992 Oct;27 Suppl 2:9-12.
7
Guidelines for therapeutic interchange-2004.治疗性药物互换指南-2004年。
Pharmacotherapy. 2005 Nov;25(11):1666-80. doi: 10.1592/phco.2005.25.11.1666.
8
Pharmacy and Therapeutics committee. Cost-containment considerations.
Arch Intern Med. 1992 Sep;152(9):1773-5.
9
Controlling financial variables--changing prescribing patterns.控制财务变量——改变处方模式。
Am J Hosp Pharm. 1984 Mar;41(3):503-15.
10
Pharmacoeconomic series: Part 3. Applying pharmacoeconomic and quality-of-life measures to the formulary management process.药物经济学系列:第3部分。将药物经济学和生活质量指标应用于处方集管理过程。
Hosp Formul. 1993 Jun;28(6):577-84.

引用本文的文献

1
The right drug, but from whose perspective? A framework for analysing the structure and activities of drug and therapeutics committees.正确的药物,但从谁的角度来看?分析药物和治疗学委员会的结构和活动的框架。
Eur J Clin Pharmacol. 2013 May;69 Suppl 1(Suppl 1):79-87. doi: 10.1007/s00228-013-1491-y. Epub 2013 May 3.